JS Skyler, L Jovanovic, S Klioze, J Reis, W … - Diabetes Care, 2007 - Am Diabetes Assoc RESULTS—The mean ± SEM annual rates of change between months 0 and 24 were
−0.051 ± 0.005 l/year with EXU and −0.034 ± 0.005 l/year with SC insulin
(significant mean difference −0.017 ± 0.007 l/year [90% CI −0.028 to ... Cited by 37 - Related articles - BL Direct - All 9 versions
P Function - members.medscape.com Patient disposition. Analyses for pulmonary function test data were performed
for the full analysis set (FEV1) of subjects and analyses for parameters of
efficacy (A1C, fasting plasma glucose, hypoglycemia, and body weight) and ... Related articles
- ►diabetesjournals.org PA Hollander, A Krasner, S Klioze, P … - Diabetes Care, 2007 - Am Diabetes Assoc Weight gain is commonly seen when patients are started on subcutaneous (SC)
insulin. In the UK Prospective Diabetes Study, those assigned insulin gained 4
kg more than those assigned conventional therapy at 10 years (1). Given ... Cited by 10 - Related articles - BL Direct - All 5 versions
- Free from Publisher MA Testa, DC Simonson - Diabetes Care, 2007 - Am Diabetes Assoc RESULTS—Overall treatment satisfaction (0–100) increased by 13.2 ± 1.1
units for inhaled insulin (baseline = 63.3 ± 1.2) compared with 1.7 ± 0.8 for
subcutaneous insulin injection (baseline = 64.1 ± 1.2, P < 0.0001). All 12 ... Cited by 12 - Related articles - BL Direct - All 8 versions
P Ltd, UK Sandwich - International journal of clinical practice - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 19 - Related articles - BL Direct - All 4 versions
- ►ucalgary.ca [PDF] - Free from Publisher JS Skyler, RS Weinstock, P Raskin, JF Yale, E … - Diabetes Care, 2005 - Am Diabetes Assoc RESULTS—Mean glycosylated hemoglobin (A1C) decreased comparably from baseline
in the inhaled and subcutaneous insulin groups (−0.3 and −0.1%,
respectively; adjusted difference −0.16% [CI −0.34 to 0.01]), with a ... Cited by 104 - Related articles - BL Direct - All 10 versions
S Garg, J Rosenstock, BL Silverman, B Sun, … - Diabetologia, 2006 - Springer Page 1. Diabetologia (2006) 49: 891–899 DOI 10.1007/s00125-006-0161-3 ARTICLE S.
Garg . J. Rosenstock . BL Silverman . B. Sun . CS Konkoy . A. de la Peña . ... Cited by 61 - Related articles - BL Direct - All 5 versions
- Free from Publisher AH Barnett, M Dreyer, P Lange, M Serdarevic … - Diabetes Care, 2006 - Am Diabetes Assoc RESULTS—In the A1C >9.5% arm, INH demonstrated a significantly greater
reduction in A1C than metformin. Mean adjusted changes from baseline were
−2.17 and −1.79%, respectively; between-treatment difference was ... Cited by 47 - Related articles - BL Direct - All 7 versions
- ►diabetesjournals.org AH Barnett, M Dreyer, P Lange, M Serdarevic … - Diabetes Care, 2006 - Am Diabetes Assoc RESULTS—Mean adjusted A1C changes from baseline were –2.03 and –1.88% in
the INH and glibenclamide groups, respectively; between-treatment difference
–0.17% (95% CI –0.34 to 0.01; P = 0.058), consistent with the ... Cited by 47 - Related articles - BL Direct - All 8 versions
M Hausmann, S Dellweg, C Osborn, L … - Diabetes Obes. Metab, 2006 - interscience.wiley.com Methods: Twenty-four subjects with type 2 diabetes [19 men and 5 women, 56.1 ±
6.6 years, body mass index 32.7 ± 4.2 kg/m 2 , glycosylated haemoglobin (HbA1c)
8.4 ± 0.8% (mean ± sd)] inadequately controlled by metformin and/or ... Cited by 13 - Related articles - All 3 versions
